Medication optimization in aging adults faces a critical blind spot that could be harming millions worldwide. While diuretics remain cornerstone treatments for heart failure and hypertension, their continued use without clear ongoing indications creates a cascade of preventable health risks that disproportionately affect older adults with complex medical conditions.
This comprehensive analysis of 41 international clinical resources revealed 184 distinct recommendations for identifying inappropriate chronic diuretic use and guiding safe medication discontinuation. The research synthesized evidence from 14 clinical practice guidelines and 27 expert assessment tools, creating the most extensive compilation of deprescribing guidance to date. Key findings highlight systematic approaches to evaluate continued diuretic necessity, particularly focusing on electrolyte monitoring, renal function assessment, and fall risk evaluation in vulnerable populations.
The timing proves particularly significant as healthcare systems grapple with polypharmacy epidemics among aging populations. Current evidence suggests that many older adults continue diuretics long after their original indication has resolved or when risks outweigh benefits. This creates a perfect storm of adverse events including dangerous electrolyte imbalances, kidney dysfunction, blood pressure drops leading to falls, and measurably reduced quality of life. The systematic compilation addresses a crucial gap in clinical decision-making tools, providing practitioners with evidence-based frameworks for safe medication reduction. However, the research exposes the fragmented nature of current deprescribing guidance, with significant variation in recommendations across different healthcare systems. This inconsistency likely contributes to clinical uncertainty and potentially delayed medication optimization, suggesting that standardized, validated deprescribing protocols represent an urgent priority for geriatric medicine and cardiovascular care.